Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Chubb
McKinsey
McKesson
Federal Trade Commission
Boehringer Ingelheim
Harvard Business School
Accenture

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021145

« Back to Dashboard

NDA 021145 describes VANIQA, which is a drug marketed by Skinmedica and is included in one NDA. It is available from one supplier. Additional details are available on the VANIQA profile page.

The generic ingredient in VANIQA is eflornithine hydrochloride. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.
Summary for 021145
Tradename:VANIQA
Applicant:Skinmedica
Ingredient:eflornithine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 021145
Mechanism of ActionDecarboxylase Inhibitors
Medical Subject Heading (MeSH) Categories for 021145
Suppliers and Packaging for NDA: 021145
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145 NDA Allergan, Inc. 0023-4857 N 0023-4857-45

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength13.9%
Approval Date:Jul 27, 2000TE:RLD:Yes

Expired US Patents for NDA 021145

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Skinmedica VANIQA eflornithine hydrochloride CREAM;TOPICAL 021145-001 Jul 27, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Boehringer Ingelheim
QuintilesIMS
Daiichi Sankyo
Baxter
Mallinckrodt
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.